Clinical verification of homoeopathic medicine Phyllanthus niruri
- Conditions
- Health Condition 1: J31- Chronic rhinitis, nasopharyngitisand pharyngitisHealth Condition 2: K590- ConstipationHealth Condition 3: R14- Flatulence and related conditionsHealth Condition 4: K591- Functional diarrheaHealth Condition 5: R51- HeadacheHealth Condition 6: R53- Malaise and fatigueHealth Condition 7: R11- Nausea and vomitingHealth Condition 8: M130- Polyarthritis, unspecifiedHealth Condition 9: K120- Recurrent oral aphthae
- Registration Number
- CTRI/2023/10/058802
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Participants presenting with minimum of three signs and symptoms corresponding to the signs and symptoms attributed to the medicines to be verified.
2. Participants presenting with acute or chronic clinical conditions as per the symptomatology mentioned in the ‘Materia Medica’ of the medicines to be verified.
3. Participants who are not taking any homoeopathic medication for their acute presenting complaints.
4. Participants who have not taken any homoeopathic medication for the past one week for their chronic complaints or those agreeing for a washout period of one week for discontinuing ongoing medications.
5. Participants willing to participate in the study and giving written informed consent/ assent.
1. Participants presenting with the clinical presentations other than the symptomatology mentioned in the ‘Materia Medica’ of the medicines to be verified.
2. Participants with a history of uncontrolled or life-threatening disease/ systemic illness (tuberculosis, cancer, AIDS, diabetes, hypertension, cardiovascular disorders etc.)
3. Any pre-existing psychiatric disorder.
4. Participants taking concomitant medications like immuno-suppressants, hormonal therapies or other Ayush therapies/ herbal medicines etc. for chronic ailments.
5. Substance abuse and/or dependence.
6. Pregnant and lactating women.
7. Participants deemed unfit by the investigator.
8. Participants not willing to give written informed consent/ assent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method